Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population

Clinical and Experimental Medicine

Volumn 8, Issue 1, 2008, Pages 51-57

  Çakatay, Ufuk ^a,b   Kayali, Refik ^c   Uzun, Hafize ^c  

^a Central Laboratory of Clinical Biochemistry ^*  (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ageing; Paraoxonase; Protein carbonyl; Protein hydroperoxide; Protein oxidation; Thiol

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ARYLDIALKYLPHOSPHATASE 1; CARBONYL DERIVATIVE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXIDE; PLASMA PROTEIN; SUPEROXIDE DISMUTASE; THIOL;

ADULT; AGED; AGING; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GROUPS BY AGE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 43449131541     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-008-0156-0     Document Type: Article

References (35)

1. Seres I, Paragh G, Deschene E et al (2004) Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 39:59-66
2. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241
3. Reaven PD, Napoli C, Merat S, Witztumc JI (2000) Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 34:527-537
4. Bonnefont-Rousselot D, Therond P, Beaudeux JL et al (1999) High density lipoproteins (HDL) and oxidative hypothesis of atherosclerosis. Clin Chem Lab Med 37:938-948
5. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550
6. Watson AD, Berliner JA, Hama SY et al (1995) Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882-2891
7. Gugliucci A, Lunceford N, Kinugasa E et al (2007) Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clin Chim Acta 384:105-112
8. Jaouad L, Guise C, Berrougui H et al (2006) Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis 185:191-200
9. Woods AA, Linton SM, Davies MJ (2003) Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J 370:729-735
10. Kaneda H, Taguchi J, Ogasawara K et al (2002) Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162:221-225
11. Şkvařilová M, Bulava A, Stejskal D et al (2005) Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Papers 149:83-87
12. Stadtman ER (2004) Role of oxidant species in aging. Curr Med Chem 11:1105-1112
13. Çakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551-557
14. Kalousová M, Zima T, Tesár V et al (2005) Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579:37-46
15. Capéillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V (2004) Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689:91-102
16. - (2002) World Medical Association Declaration Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med 48:206-208
17. Bridges AB, Fisher TC, Scot N et al (1992) Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res 16:89-97
18. Hasselwander O, Savage DA, McMaster D et al (1999) Paraoxonase polymorphism are not associated with cardiovascular risk in renal transplants recipients. Kidney Int 56:289-298
19. Saha N, Roy AC, Teo SH et al (1991) Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 40:277-282
20. Paragh G, Asztalos L, Seres I et al (1999) Serum paraoxonase activity changes in uremic and kidney transplanted patients. Nephron 83:126-131
21. Eckerson HW, Romson J, Wyte C, La Du BN (1983) The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 35:214-227
22. Gay CA, Gebicki JM (2003) Measurement of protein and lipid hydroperoxides in biological systems by the ferric-xylenol orange method. Anal Biochem 315:29-35
23. Zbikowska HM, Nowak P, Wachowicz B (2006) Protein modification caused by a high dose of gamma irradiation in cryo-sterilized plasma: Protective effects of ascorbate. Free Radic Biol Med 40:536-542
24. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357-363
25. Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:381-385
26. Witko-Sarsat V, Friedlander M, Capéillere-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313
27. Çakatay U, Kayali R (2005) Plasma protein oxidation in aging rats after alpha-lipoic acid administration. Biogerontology 6:87-93
28. Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54:176-186
29. Alderman C, Shah S, Foreman JC et al (2002) The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 32:377-385
30. Gieseg S, Duggan S, Gebicki JM (2000) Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals. Biochem J 350:215-218
31. Gebicki S, Gebicki JM (1999) Cross-linking of DNA and proteins induced by protein hydroperoxides. Biochem J 338:629-636
32. Davies MJ, Fu S, Dean RT (1995) Protein hydroperoxides can give rise to reactive free radicals. Biochem J 305:643-649
33. Soszynski M, Filipiak A, Bartosz G, Gebicki JM (1996) Effect of amino acid peroxides on the erythrocyte. Free Radic Biol Med 20:45-51
34. Eaton P (2006) Protein thiol oxidation in health and disease. Techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic Biol Med 40:1889-1899
35. Morgan PE, Dean RT, Davies MJ (2005) Inhibition of glyceraldehyde-3- phosphate dehydrogenase by peptide and protein peroxides generated by singlet oxygen attack. Eur J Biochem 269:1916-1925